The Venture Codex Logo

The Venture Codex

Shengde Pharmaceutical Group

3-1-2509 Wanda Plaza, Guangyang District, Langfang, Hebei, China

Overview

Pharmaceutical company specializing in APIs and technology R&D.

Deals · 12mo

0

Links

Website

Stage focus

Series A

Geographic focus

China

Sector focus

—

Investment portfolio

1rounds
NAMEDATESIZE
GenEditBio
Apr 2024Led
$10 MSeries A
GenEditBio
Apr 2024Led
$10 MSeries A
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Shengde Pharmaceutical Group: 1 funding rounds are recorded in the selected participation categories.All available history.
Shengde Pharmaceutical Group: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10

Monthly Deal Activity

Shengde Pharmaceutical Group: 1 deals are recorded across 31 months.All available history.
Shengde Pharmaceutical Group: 1 deals are recorded across 31 months. All available history
MonthDeals
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Shengde Pharmaceutical Group: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Shengde Pharmaceutical Group: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1

Deal Size Distribution

Shengde Pharmaceutical Group: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Shengde Pharmaceutical Group: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Shengde Pharmaceutical Group: China has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Shengde Pharmaceutical Group: China has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
China1
Shengde Pharmaceutical Group: 3 co-investors are shown, with Hong Kong Science and Technology Parks Corporation sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Shengde Pharmaceutical Group: 3 co-investors are shown, with Hong Kong Science and Technology Parks Corporation sharing 1 recorded deals. All available history
Co-investorShared deals
Hong Kong Science and Technology Parks Corporation1
Qiming Venture Partners1
Shuntian Pharmaceutical1

Investment Strategy

Shengde Pharmaceutical Group: Led accounts for 100% and participating for 0% of round participation.All available history.
Shengde Pharmaceutical Group: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Shengde Pharmaceutical Group: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Shengde Pharmaceutical Group: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

No team members found for this fund.